Operation Smile Featured in “Beyond the Code,” a New Branded Series that Explores How AI Is Driving Transformative Change
VIRGINIA BEACH, Va., Oct. 15, 2024 /PRNewswire/ -- Global nonprofit Operation Smile today announced its involvement in Beyond the Code, a new branded series presented by Partnership on AI (PAI) and produced by BBC StoryWorks Commercial Productions. The first of its kind, this online series – which includes a story produced for Operation Smile of how AI is improving...
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
HONG KONG, Oct. 15, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong-based early cancer detection company. This investment values Insighta at US$200 million and underscores Tencent's endeavor to advancing AI-powered innovations in healthcare. Following the transaction, Prenetics' stake in...
Gan & Lee Pharmaceuticals’ Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies
After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide (Ozempic®). After 16 weeks of treatment in patients with Type 2 diabetes, the once-weekly insulin analog GZR4 injection demonstrated superior HbA1c...
Endogenex™ Announces First Patient Enrolled in the ReCET Clinical Study
Achieving a Significant Clinical Milestone in Assessing the ReCET™ System as a Groundbreaking Treatment for Type 2 Diabetes MINNEAPOLIS, Oct. 15, 2024 /PRNewswire/ -- Endogenex, Inc., a clinical-stage medical device company focused on improving outcomes for patients with type 2 diabetes (T2D), today announced the enrollment of the first patient in the...
Empowering Experience through Digital, Humanizing Technology for All: vivo Unveils Vision in the Future of Mobile Imaging at the Global Imaging Press Conference
BEIJING, Oct. 15, 2024 /PRNewswire/ -- vivo, a global leader in mobile technology, successfully convened the 2024 vivo Global Imaging Press Conference in Beijing today, bringing together over 100 global media representatives. Following the unveiling of the latest vivo X200 series, the conference explored the brand's journey of imaging innovations and its strategic vision for shaping the future of mobile...
Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry
DONGGUAN, China, Oct. 15, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is excited to participate in the Hospital Expo in Jakarta, Indonesia, from October 16 – 19. Fapon will showcase its total IVD solutions, including IVD raw materials, reagent services and open-system instruments, all designed to support and empower local...
Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program
83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON, Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureates™ program, following the accurate forecast of eight Nobel Prize 2024 recipients. Powered...
DBN Group Invites Global Agricultural Biotech Companies to Co-create a Leading Innovation Ecosystem at DBN Phoenix International Innovation Park
BEIJING, Oct. 15, 2024 /PRNewswire/ -- DBN Group, a leading high-tech agricultural enterprise, has opened its Phoenix International Innovation Park for global applications from high-quality agricultural biotech companies. This initiative seeks to establish an open innovation and entrepreneurship ecosystem by harnessing cutting-edge technologies and international collaboration, positioning the park as a key player in advancing agricultural technology globally. DBN Phoenix...
Aidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New Zealand
Aidoc's AI technology enhances radiology services at IDX, significantly improving patient care and service and well-placed to support the upcoming National Lung Cancer Screening Program. MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Aidoc, a global pioneer in clinical AI solutions, today announced the expansion of its partnership with Integral Diagnostics (IDX), the...
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration
Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. PMC-403 is being explored in broader therapeutic areas, including rare vascular disease systemic capillary leak syndrome (SCLS) and kidney diseases. DAEJEON, South Korea, Oct. 15, 2024...
